These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
496 related articles for article (PubMed ID: 30205580)
1. The Effects of Berberine on the Gut Microbiota in Apc Wang H; Guan L; Li J; Lai M; Wen X Molecules; 2018 Sep; 23(9):. PubMed ID: 30205580 [No Abstract] [Full Text] [Related]
2. Berberine inhibits high fat diet-associated colorectal cancer through modulation of the gut microbiota-mediated lysophosphatidylcholine. Chen H; Ye C; Wu C; Zhang J; Xu L; Wang X; Xu C; Zhang J; Guo Y; Yao Q Int J Biol Sci; 2023; 19(7):2097-2113. PubMed ID: 37151876 [TBL] [Abstract][Full Text] [Related]
3. Anti-obesity and Gut Microbiota Modulation Effect of Astragalus Polysaccharides Combined with Berberine on High-Fat Diet-Fed Obese Mice. Yue SJ; Wang WX; Zhang L; Liu J; Feng WW; Gao H; Tang YP; Yan D Chin J Integr Med; 2023 Jul; 29(7):617-625. PubMed ID: 34921647 [TBL] [Abstract][Full Text] [Related]
4. Berberine treatment reduces atherosclerosis by mediating gut microbiota in apoE-/- mice. Shi Y; Hu J; Geng J; Hu T; Wang B; Yan W; Jiang Y; Li J; Liu S Biomed Pharmacother; 2018 Nov; 107():1556-1563. PubMed ID: 30257374 [TBL] [Abstract][Full Text] [Related]
5. A Holistic View of Berberine Inhibiting Intestinal Carcinogenesis in Conventional Mice Based on Microbiome-Metabolomics Analysis. Chen H; Zhang F; Zhang J; Zhang X; Guo Y; Yao Q Front Immunol; 2020; 11():588079. PubMed ID: 33072135 [TBL] [Abstract][Full Text] [Related]
6. Berberine treatment increases Akkermansia in the gut and improves high-fat diet-induced atherosclerosis in Apoe Zhu L; Zhang D; Zhu H; Zhu J; Weng S; Dong L; Liu T; Hu Y; Shen X Atherosclerosis; 2018 Jan; 268():117-126. PubMed ID: 29202334 [TBL] [Abstract][Full Text] [Related]
7. Berberine inhibits intestinal carcinogenesis by suppressing intestinal pro-inflammatory genes and oncogenic factors through modulating gut microbiota. Chen H; Ye C; Cai B; Zhang F; Wang X; Zhang J; Zhang Z; Guo Y; Yao Q BMC Cancer; 2022 May; 22(1):566. PubMed ID: 35596224 [TBL] [Abstract][Full Text] [Related]
8. Berberine alters gut microbial function through modulation of bile acids. Wolf PG; Devendran S; Doden HL; Ly LK; Moore T; Takei H; Nittono H; Murai T; Kurosawa T; Chlipala GE; Green SJ; Kakiyama G; Kashyap P; McCracken VJ; Gaskins HR; Gillevet PM; Ridlon JM BMC Microbiol; 2021 Jan; 21(1):24. PubMed ID: 33430766 [TBL] [Abstract][Full Text] [Related]
9. Berberine alleviates insulin resistance by reducing peripheral branched-chain amino acids. Yue SJ; Liu J; Wang AT; Meng XT; Yang ZR; Peng C; Guan HS; Wang CY; Yan D Am J Physiol Endocrinol Metab; 2019 Jan; 316(1):E73-E85. PubMed ID: 30422704 [TBL] [Abstract][Full Text] [Related]
10. Berberine-induced bioactive metabolites of the gut microbiota improve energy metabolism. Wang Y; Shou JW; Li XY; Zhao ZX; Fu J; He CY; Feng R; Ma C; Wen BY; Guo F; Yang XY; Han YX; Wang LL; Tong Q; You XF; Lin Y; Kong WJ; Si SY; Jiang JD Metabolism; 2017 May; 70():72-84. PubMed ID: 28403947 [TBL] [Abstract][Full Text] [Related]
11. Aspirin Reduces Colorectal Tumor Development in Mice and Gut Microbes Reduce its Bioavailability and Chemopreventive Effects. Zhao R; Coker OO; Wu J; Zhou Y; Zhao L; Nakatsu G; Bian X; Wei H; Chan AWH; Sung JJY; Chan FKL; El-Omar E; Yu J Gastroenterology; 2020 Sep; 159(3):969-983.e4. PubMed ID: 32387495 [TBL] [Abstract][Full Text] [Related]
12. Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway. Sun R; Yang N; Kong B; Cao B; Feng D; Yu X; Ge C; Huang J; Shen J; Wang P; Feng S; Fei F; Guo J; He J; Aa N; Chen Q; Pan Y; Schumacher JD; Yang CS; Guo GL; Aa J; Wang G Mol Pharmacol; 2017 Feb; 91(2):110-122. PubMed ID: 27932556 [TBL] [Abstract][Full Text] [Related]
13. N-Acetylcysteine alleviates gut dysbiosis and glucose metabolic disorder in high-fat diet-fed mice. Zheng J; Yuan X; Zhang C; Jia P; Jiao S; Zhao X; Yin H; Du Y; Liu H J Diabetes; 2019 Jan; 11(1):32-45. PubMed ID: 29845722 [TBL] [Abstract][Full Text] [Related]
14. Berberine alleviates type 2 diabetic symptoms by altering gut microbiota and reducing aromatic amino acids. Yao Y; Chen H; Yan L; Wang W; Wang D Biomed Pharmacother; 2020 Nov; 131():110669. PubMed ID: 32937246 [TBL] [Abstract][Full Text] [Related]
15. Evolutionary biologic changes of gut microbiota in an 'adenoma-carcinoma sequence' mouse colorectal cancer model induced by 1, 2-Dimethylhydrazine. Sun T; Liu S; Zhou Y; Yao Z; Zhang D; Cao S; Wei Z; Tan B; Li Y; Lian Z; Wang S Oncotarget; 2017 Jan; 8(1):444-457. PubMed ID: 27880935 [TBL] [Abstract][Full Text] [Related]
16. Gut Microbiota-Mediated Personalized Treatment of Hyperlipidemia Using Berberine. Wang Y; Tong Q; Shou JW; Zhao ZX; Li XY; Zhang XF; Ma SR; He CY; Lin Y; Wen BY; Guo F; Fu J; Jiang JD Theranostics; 2017; 7(9):2443-2451. PubMed ID: 28744326 [TBL] [Abstract][Full Text] [Related]
17. High-Fat Diet Promotes Colorectal Tumorigenesis Through Modulating Gut Microbiota and Metabolites. Yang J; Wei H; Zhou Y; Szeto CH; Li C; Lin Y; Coker OO; Lau HCH; Chan AWH; Sung JJY; Yu J Gastroenterology; 2022 Jan; 162(1):135-149.e2. PubMed ID: 34461052 [TBL] [Abstract][Full Text] [Related]
18. The berberine-enriched gut commensal Blautia producta ameliorates high-fat diet (HFD)-induced hyperlipidemia and stimulates liver LDLR expression. Yang YN; Wang QC; Xu W; Yu J; Zhang H; Wu C Biomed Pharmacother; 2022 Nov; 155():113749. PubMed ID: 36174380 [TBL] [Abstract][Full Text] [Related]
19. Gut Microbiota Mediates the Protective Effects of Dietary Capsaicin against Chronic Low-Grade Inflammation and Associated Obesity Induced by High-Fat Diet. Kang C; Wang B; Kaliannan K; Wang X; Lang H; Hui S; Huang L; Zhang Y; Zhou M; Chen M; Mi M mBio; 2017 May; 8(3):. PubMed ID: 28536285 [TBL] [Abstract][Full Text] [Related]
20. Effect of atorvastatin on the gut microbiota of high fat diet-induced hypercholesterolemic rats. Khan TJ; Ahmed YM; Zamzami MA; Mohamed SA; Khan I; Baothman OAS; Mehanna MG; Yasir M Sci Rep; 2018 Jan; 8(1):662. PubMed ID: 29330433 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]